Drug Target Review

JUNE 29, 2023

Regarding the NY-ESO programme that we worked on, I started work on that in 2002 before we even knew that we were going to do cell therapy. I think the cell-therapy field has evolved a lot – and is continuing to do so – in the time I’ve been working with this.

Therapies 115

Therapies Science Production Cell Biology 115

PLOS: DNA Science

JUNE 1, 2023

DEB has been a candidate for a gene therapy since 2002. “Until now, doctors and nurses had no way to stop blisters and wounds from developing on dystrophic EB patient skin and all we could do was to give them bandages and helplessly watch as new blisters formed. RDEB is inherited from two carrier parents. Primary investigator M.

FDA Approval 52

FDA Approval Therapies FDA Disease 52

PLOS: DNA Science

JULY 11, 2024

The animals were cloned from DNA in bits of preserved ear bones, and doctored a bit. Dolly predates the start of the sheep genome project in 2002, which was completed in 2016. million to 11,700 years ago. The resulting animals roam a resort nestled into the remote Colorado Rockies, thanks to biotech company Erebus.

DNA 52

DNA Science Doctors Engineering 52

The Pharma Data

MAY 14, 2021

Back in 2002, God sent me the most important message of my life. My doctor explained that it was possible but that most people usually have to take them (the meds) the rest of their lives so not to worry about it too much and try to lose a little weight if you can. And it was the inspiration behind me becoming an….

Production 52

Production Engineering Vaccine Science 52

Drug & Device Law

AUGUST 28, 2023

435, 436 (2002). Even worse is standing based on the “considerable mental and emotional stress on emergency-room doctors,” purported injury from “divert[ing] time and resources away from their ordinary practice to treat [adverse reaction] patients, and even the possibility of increased malpractice insurance costs. Gore ,” 35 Ind.

FDA 52

FDA FDA Approval Doctors Production 52

Drug & Device Law

SEPTEMBER 11, 2023

435, 436 (2002). Even worse is standing based on the “considerable mental and emotional stress on emergency-room doctors,” purported injury from “divert[ing] time and resources away from their ordinary practice to treat [adverse reaction] patients, and even the possibility of increased malpractice insurance costs. Gore ,” 35 Ind.

FDA Approval 59

FDA Approval FDA Doctors Production 59

Drug & Device Law

DECEMBER 4, 2023

2002). “[I]t is not the role of a federal court to expand state law in ways not foreshadowed by state precedent.” Taking the good doctor first, In re Philips Recalled CPAP, Bi-Level Pap, & Mechanical Ventilator Products Litigation , 2023 WL 7019667 (Sp. Ford Motor Co. , 3d 661, 680 (3d Cir. City of Philadelphia v. Beretta U.S.A.

Production 52

Production Trials Treatment Pharmaceuticals 52

Drug & Device Law

JUNE 6, 2022

Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” June 29, 2017) (no causation where “[t]he prescribing doctors would not have changed their prescriptions based on what they now know about [the drug]”); Lord v. Schering Corp. , 2d 1140, 1148 (N.J.

Testimonials 59

Testimonials Production Pharmaceuticals Treatment 59

Drug & Device Law

MAY 30, 2022

The law presumes that licensed doctors know what they are doing. 1978), where a hypertensive patient was injured after being injected with the defendant’s drug – despite warnings that “expressly directed the doctor administering the drug to refrain from giving it to a patient with hypertension.” Best Pharmacal , 577 P.2d Robins Co. ,

Testimonials 59

Testimonials Doctors Production Laboratories 59

Drug & Device Law

NOVEMBER 9, 2023

357 (2002); United States v. That’s a significant step forward, since it aligns the FDA’s view of permissible science more closely to what doctors (and Medicare) actually rely on in clinical situations. E.g. , Sorrell v. IMS Health Inc. , 552 (2011); Thompson v. Western States Medical Center , 535 U.S. Caronia , 703 F.3d FDA , 119 F.

FDA 64

FDA Nurses Production Regulations 64

Drug & Device Law

NOVEMBER 10, 2022

3, 2002) (to be published), the California Court of Appeal held that federal law preempts state law failure-to-warn claims alleging that branded and generic drug manufacturers did not ensure that patients received FDA-approved Medication Guides for amiodarone, a heart medicine. In Amiodarone Cases , No. A161023, 2022 WL 16646728 (Cal.

FDA Approval 52

FDA Approval FDA Doctors Government 52

Drug & Device Law

JUNE 13, 2022

2002), which rejected a Georgia plaintiff’s contention that a medical device manufacturer had a duty to place a warning on the product itself “that third parties should not activate the PCA pump on behalf of the patient to whom it is prescribed.” Bard, Inc. , 3d 1272 (11th Cir.

Testimonials 59

Testimonials Licensing Licensing FDA 59

Drug & Device Law

SEPTEMBER 9, 2022

4th –, 2002 WL 3696680 (6th Cir. 2002), a pelvic mesh case that made its way from years languishing in an MDL to summary judgment in the transferee court to an appeal to the Sixth Circuit. 2002 WL 3696680, *5. It focused squarely on the doctor. 2002 WL 3696680, *6. Fast forward to Thacker v. Ethicon, Inc. , — F.4th

Doctors 59

Doctors Testimonials Production Trials 59